Ocugen Files Definitive Proxy Statement for 2024 Shareholder Meeting

Ticker: OCGN · Form: DEF 14A · Filed: May 28, 2024 · CIK: 1372299

Ocugen, INC. DEF 14A Filing Summary
FieldDetail
CompanyOcugen, INC. (OCGN)
Form TypeDEF 14A
Filed DateMay 28, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.01, $1.6 billion
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

Related Tickers: OCGN

TL;DR

Ocugen's proxy statement is out for the June 28th meeting - vote on directors & auditors!

AI Summary

Ocugen, Inc. filed its definitive proxy statement for the 2024 Annual Meeting of Stockholders, scheduled for June 28, 2024. The filing outlines proposals for the election of directors, ratification of the independent registered public accounting firm, and other business as may properly come before the meeting. The company is seeking shareholder approval for these matters to continue its operations and strategic initiatives.

Why It Matters

This filing is crucial for shareholders as it details the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions on the company's future direction and governance.

Risk Assessment

Risk Level: medium — Proxy statements are routine filings, but the specific proposals and the company's financial health can introduce medium risk.

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose is to provide shareholders with information and solicit their votes for the upcoming 2024 Annual Meeting of Stockholders.

When is the 2024 Annual Meeting of Stockholders scheduled to take place?

The 2024 Annual Meeting of Stockholders is scheduled for June 28, 2024.

What are the main proposals to be voted on at the meeting?

The main proposals include the election of directors and the ratification of the appointment of the independent registered public accounting firm.

Who is the filer of this proxy statement?

Ocugen, Inc. is the registrant and the filer of this proxy statement.

What is the company's Central Index Key (CIK)?

Ocugen, Inc.'s Central Index Key (CIK) is 0001372299.

Filing Stats: 4,453 words · 18 min read · ~15 pages · Grade level 12.4 · Accepted 2024-05-28 16:05:59

Key Financial Figures

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS & MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS & MANAGEMENT 59 GENERAL INFORMATION 61 TABLE OF CONTENTS NOTICE OF ANNUAL MEETING DEAR STOCKHOLDER: You are invited to attend Ocugen, Inc.'s Annual Meeting of Stockholders (the "Annual Meeting") on Friday, June 28, 2024, at 8:00 a.m. Eastern Time. This year's Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via a live audio webcast. You will be able to attend the Annual Meeting online, vote electronically and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/OCGN2024. At the Annual Meeting, stockholders will vote on: Election of Class I Directors for a Three-Year Term Expiring in 2027. 1. Shankar Musunuri, Ph. D., MBA 2. Junge Zhang, Ph. D. Ratification of Appointment of Ernst & Young LLP as Ocugen, Inc. Independent Registered Public Accounting Firm for 2024. Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers (the "NEOs"). Approval of an amendment to Ocugen, Inc.'s Sixth Amended and Restated Certificate of Incorporation, as amended (the "Charter") to limit the liability of certain officers of Ocugen, Inc. as permitted by recent amendments to the Delaware General Corporation Law ("DGCL"). Approval of an amendment to our Charter to increase the number of authorized shares of common stock. Approval of an amendment to Ocugen, Inc.'s Charter to adjust voting requirements for certain future amendments to our Charter in accordance with recent amendments to Section 242(d) of the DGCL. Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 1–6. Stockholders will also transact any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting. VOTING You are entitled t

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing